表紙:等温核酸増幅技術 (INAAT) の世界市場 (2022-2028年):市場予測 (技術・製品・用途・エンドユーザー別)・地域的展望・成長の潜在性・市場シェア
市場調査レポート
商品コード
1073226

等温核酸増幅技術 (INAAT) の世界市場 (2022-2028年):市場予測 (技術・製品・用途・エンドユーザー別)・地域的展望・成長の潜在性・市場シェア

Isothermal Nucleic Acid Amplification Technology Market Size By Technology, Product, Application, End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 160 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
等温核酸増幅技術 (INAAT) の世界市場 (2022-2028年):市場予測 (技術・製品・用途・エンドユーザー別)・地域的展望・成長の潜在性・市場シェア
出版日: 2022年04月12日
発行: Global Market Insights Inc.
ページ情報: 英文 160 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

等温核酸増幅技術 (INAAT) の市場は、診断技術の顕著な進歩により、2028年にかけて大きく成長すると予測されています。

R&D活動への海外投資の増加やポイントオブケア (PoC) 検査の需要の拡大も予測期間中の産業の進展を後押しする見通しです。

技術別で見ると、癌の病原体検出の実現に向けた需要の高まりにより、ストランド変位増幅 (SDA) 技術の部門が予測期間中に約12%のCAGRで大きく成長すると予測されています。また、製品別では、機器の部門が2021年に3億8,300万米ドル超の規模を示し、予測期間中も安定的に成長すると予測されています。さまざまな地域で技術的に高度な診断機器に対する需要が高まっていることが予測期間中の成長を促進する見通しです。

当レポートでは、世界の等温核酸増幅技術 (INAAT) の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 等温核酸増幅技術 (INAAT) 産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性の分析
  • COVID-19:影響分析
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 等温核酸増幅技術 (INAAT) 市場:技術別

  • 主要動向
  • ループ媒介等温増幅 (LAMP)
  • ストランド変位増幅 (SDA)
  • 核酸配列ベース増幅 (NASBA)
  • ヘリカーゼ依存性増幅 (HDA)
  • その他

第5章 等温核酸増幅技術 (INAAT) 市場:製品別

  • 主要動向
  • 機器
  • 試薬

第6章 等温核酸増幅技術 (INAAT) 市場:用途別

  • 主要動向
  • 感染症
    • HIV
    • インフルエンザ
    • マラリア
    • 結核
  • 腫瘍
  • 血液スクリーニング
  • その他

第7章 等温核酸増幅技術 (INAAT) 市場:エンドユーザー別

  • 主要動向
  • 病院
  • 診断ラボ
  • その他

第8章 等温核酸増幅技術 (INAAT) 市場:地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 企業プロファイル

  • 競合ダッシュボード
  • Becton, Dickinson and Company
  • Abbott(Alere)
  • BioMerieux SA
  • Eiken Chemical Co. Ltd
  • Hologic Inc.(Gen-Probe)
  • Lucigen
  • Meridian Bioscience, Inc.
  • OptiGene Limited
  • Qiagen NV
  • Quidel Corporation
  • Tecan Genomics Inc.
  • Thermo Fisher Scientific Inc.
  • Ustar Biotechnologies Ltd.
  • Grifols, S.A.
図表

Data Tables

  • TABLE 1 Isothermal nucleic acid amplification technology (INAAT) market, 2017 - 2021, (USD Million)
  • TABLE 2 Isothermal nucleic acid amplification technology (INAAT) market, 2022 - 2028, (USD Million)
  • TABLE 3 Isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 4 Isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 5 Isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 6 Isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 7 Isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 8 Isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 9 Isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 10 Isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 11 Isothermal nucleic acid amplification technology (INAAT) market by region, 2017 - 2021 (USD Million)
  • TABLE 12 Isothermal nucleic acid amplification technology (INAAT) market by region, 2022 - 2028 (USD Million)
  • TABLE 13 Industry impact forces
  • TABLE 14 Helicase-dependent amplification (HDA) market by region, 2017 - 2021 (USD Million)
  • TABLE 15 Helicase-dependent amplification (HDA) market by region, 2022 - 2028 (USD Million)
  • TABLE 16 Loop-mediated Isothermal Amplification (LAMP) market by region, 2017 - 2021 (USD Million)
  • TABLE 17 Loop-mediated Isothermal Amplification (LAMP) market by region, 2022 - 2028 (USD Million)
  • TABLE 18 Strand displacement amplification (SDA) market by region, 2017 - 2021 (USD Million)
  • TABLE 19 Strand displacement amplification (SDA) market by region, 2022 - 2028 (USD Million)
  • TABLE 20 Nucleic acid sequence-based amplification (NASBA) market by region, 2017 - 2021 (USD Million)
  • TABLE 21 Nucleic acid sequence-based amplification (NASBA) market by region, 2022 - 2028 (USD Million)
  • TABLE 22 Others market by region, 2017 - 2021 (USD Million)
  • TABLE 23 Others market by region, 2022 - 2028 (USD Million)
  • TABLE 24 Instruments market by region, 2017 - 2021 (USD Million)
  • TABLE 25 Instruments market by region, 2022 - 2028 (USD Million)
  • TABLE 26 Reagents market by region, 2017 - 2021 (USD Million)
  • TABLE 27 Reagents market by region, 2022 - 2028 (USD Million)
  • TABLE 28 Infectious disease market by region, 2017 - 2021 (USD Million)
  • TABLE 29 Infectious disease market by region, 2022 - 2028 (USD Million)
  • TABLE 30 Oncology market by region, 2017 - 2021 (USD Million)
  • TABLE 31 Oncology market by region, 2022 - 2028 (USD Million)
  • TABLE 32 Blood screening market by region, 2017 - 2021 (USD Million)
  • TABLE 33 Blood screening market by region, 2022 - 2028 (USD Million)
  • TABLE 34 Others market by region, 2017 - 2021 (USD Million)
  • TABLE 35 Others market by region, 2022 - 2028 (USD Million)
  • TABLE 36 North America isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)
  • TABLE 37 North America isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)
  • TABLE 38 North America isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 39 North America isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 40 North America isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 41 North America isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 42 North America isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 43 North America isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 44 North America isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 45 North America isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 46 North America isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 47 North America isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 48 U.S. isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 49 U.S. isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 50 U.S. isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 51 U.S. isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 52 U.S. isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 53 U.S. isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 54 U.S. isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 55 U.S. isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 56 U.S. isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 57 U.S. isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 58 Canada isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 59 Canada isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 60 Canada isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 61 Canada isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 62 Canada isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 63 Canada isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 64 Canada isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 65 Canada isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 66 Canada isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 67 Canada isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 68 Europe isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)
  • TABLE 69 Europe isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)
  • TABLE 70 Europe isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 71 Europe isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 72 Europe isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 73 Europe isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 74 Europe Isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 75 Europe isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 76 Europe isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 77 Europe isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 78 Europe isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 79 Europe isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 80 Germany isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 81 Germany isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 82 Germany isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 83 Germany isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 84 Germany isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 85 Germany isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 86 Germany isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 87 Germany isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 88 Germany isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 89 Germany isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 90 UK isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 91 UK isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 92 UK isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 93 UK isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 94 UK isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 95 UK isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 96 UK isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 97 UK isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 98 UK isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 99 UK isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 100 France isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 101 France isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 102 France isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 103 France isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 104 France isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 105 France isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 106 France isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 107 France isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 108 France isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 109 France isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 110 Spain isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 111 Spain isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 112 Spain isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 113 Spain isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 114 Spain isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 115 Spain isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 116 Spain isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 117 Spain isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 118 Spain isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 119 Spain isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 120 Italy isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 121 Italy isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 122 Italy isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 123 Italy isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 124 Italy isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 125 Italy isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 126 Italy isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 127 Italy isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 128 Italy isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 129 Italy isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 130 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)
  • TABLE 131 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)
  • TABLE 132 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 133 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 134 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 135 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 136 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 137 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 138 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 139 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 140 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 141 Asia Pacific isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 142 Japan isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 143 Japan isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 144 Japan isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 145 Japan isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 146 Japan isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 147 Japan isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 148 Japan isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 149 Japan isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 150 Japan isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 151 Japan isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 152 China isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 153 China isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 154 China isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 155 China isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 156 China isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 157 China isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 158 China isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 159 China isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 160 China isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 161 China isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 162 India isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 163 India isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 164 India isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 165 India isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 166 India isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 167 India isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 168 India isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 169 India isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 170 India isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 171 India isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 172 Australia isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 173 Australia isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 174 Australia isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 175 Australia isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 176 Australia isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 177 Australia isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 178 Australia isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 179 Australia isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 180 Australia isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 181 Australia isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 182 Latin America isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)
  • TABLE 183 Latin America isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)
  • TABLE 184 Latin America isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 185 Latin America isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 186 Latin America isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 187 Latin America isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 188 Latin America isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 189 Latin America isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 190 Latin America isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 191 Latin America isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 192 Latin America isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 193 Latin America isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 194 Brazil isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 195 Brazil isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 196 Brazil isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 197 Brazil isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 198 Brazil isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 199 Brazil isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 200 Brazil isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 201 Brazil isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 202 Brazil isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 203 Brazil isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 204 Mexico isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 205 Mexico isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 206 Mexico isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 207 Mexico isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 208 Mexico isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 209 Mexico isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 210 Mexico isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 211 Mexico isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 212 Mexico isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 213 Mexico isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 214 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by country, 2017 - 2021, (USD Million)
  • TABLE 215 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by country, 2022 - 2028, (USD Million)
  • TABLE 216 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 217 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 218 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 219 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 220 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 221 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 222 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 223 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 224 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 225 Middle East and Africa isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 226 South Africa isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 227 South Africa isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 228 South Africa isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 229 South Africa isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 230 South Africa isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 231 South Africa isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 232 South Africa isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 233 South Africa isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 234 South Africa isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 235 South Africa isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)
  • TABLE 236 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by technology, 2017 - 2021, (USD Million)
  • TABLE 237 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by technology, 2022 - 2028, (USD Million)
  • TABLE 238 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by product, 2017 - 2021, (USD Million)
  • TABLE 239 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by product, 2022 - 2028, (USD Million)
  • TABLE 240 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by application, 2017 - 2021, (USD Million)
  • TABLE 241 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by application, 2022 - 2028, (USD Million)
  • TABLE 242 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2017 - 2021, (USD Million)
  • TABLE 243 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by infectious disease, 2022 - 2028, (USD Million)
  • TABLE 244 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2017 - 2021, (USD Million)
  • TABLE 245 Saudi Arabia isothermal nucleic acid amplification technology (INAAT) market, by end-use, 2022 - 2028, (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Isothermal nucleic acid amplification technology (INAAT), 2017 - 2028 (USD Million)
  • FIG. 3 Growth potential analysis, by technology
  • FIG. 4 Growth potential analysis, by product
  • FIG. 5 Growth potential analysis, by application
  • FIG. 6 Growth potential analysis, by end-use
  • FIG. 7 Porter's analysis
  • FIG. 8 PESTEL analysis
  • FIG. 9 Key segment trends, by technology
  • FIG. 10 Key segment trends, by product
  • FIG. 11 Key segment trends, by application
  • FIG. 12 Key segment trends, by end-use
  • FIG. 13 Key regional trends
  • FIG. 14 Competitive dashboard, 2021
目次
Product Code: 5251

The isothermal nucleic acid amplification technology (INAAT) market is expected to witness notable growth by 2028 on account of notable advancements in diagnostic technology. In addition, growing foreign investments in research and development activities, along with expanding demand for point-of-care (PoC) testing, are set to further boost industry progress through the forecast timespan.

The coronavirus pandemic has positively impacted the market landscape, INAAT offers easy detection and minimal operation qualities, which has promoted technology adoption. Moreover, prevalent focus on fabricating innovative INAAT tools for easy use in COVID-19 testing has enhanced overall market dynamics during the pandemic.

For instance, in March 2022, a study published in Global Challenges found that T-cup, a low-cost home device for isothermal nucleic acid amplification, could be used to detect the SARS-CoV2 RNA through loop-mediated amplification (LAMP) tests. The t-cup device is easier to produce and use as well as has little environmental impact compared to existing devices available in the market.

The isothermal nucleic acid amplification technology (INAAT) market has been split with respect to product, technology, application, end-use, and region. Based on technology, the industry has been further divided into helicase-dependent amplification (HDA), strand displacement amplification, loop-mediated isothermal amplification, nucleic acid sequence-based amplification (NASBA), and other technologies. The SDA technology segment is projected to witness significant growth at around 12% CAGR over the study period owing to rising demand to achieve the detection of pathogens in cancer.

In terms of product, the isothermal nucleic acid amplification technology (INAAT) market has been categorized into instruments and reagents. The instruments segment was valued at more than USD 383 million in 2021 and is foreseen to grow steadily over 2022-2028. Mounting demand for technologically advanced diagnostic equipment across different regions is expected to foster segmental expansion in the analysis period.

With regards to application, the INAAT market has been classified into oncology, infectious diseases, blood screening, and others. The oncology segment is estimated to depict approximately 12% CAGR through the review time period on account of the growing cancer patient pool across the globe.

With reference to end-use, the isothermal nucleic acid amplification technology (INAAT) market has been segregated into hospitals, diagnostic laboratories, and others. In 2021, the diagnostic laboratories segment was valued at above USD 380 million and is primed to observe strong growth through 2028. This growth is attributed to surging awareness about diagnostic facilities.

With respect to the region covered, the Latin America isothermal nucleic acid amplification technology (INAAT) market is anticipated to grow substantially at a CAGR of nearly 13% over the review period.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Isothermal Nucleic Acid Amplification Technology (INAAT) testing industry 360 degree synopsis, 2017 - 2028
    • 2.1.1 Business trends
    • 2.1.2 Technology trends
    • 2.1.3 Products trends
    • 2.1.4 Application trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of infectious diseases
      • 3.3.1.2 Increasing adoption of INAAT over PCR
      • 3.3.1.3 Increasing blood transfusion
      • 3.3.1.4 Rise in demand for low-cost and effective diagnostics procedures
      • 3.3.1.5 Technological advancements to boost market growth
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Lack of awareness about new diagnostics technologies
      • 3.3.2.2 Opposition from PCR technologies will pose a major challenge
  • 3.4 Growth potential analysis
    • 3.4.1 By technology
    • 3.4.2 By product
    • 3.4.3 By application
    • 3.4.4 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2021
    • 3.7.1 Company matrix analysis, 2021
  • 3.8 PESTEL analysis

Chapter 4 Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology

  • 4.1 Key segment trends
  • 4.2 Loop-mediated Isothermal Amplification (LAMP)
    • 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.3 Strand Displacement Amplification (SDA)
    • 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.4 Nucleic Acid Sequence-based Amplification (NASBA)
    • 4.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.5 Helicase-dependent Amplification (HDA)
    • 4.5.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.6 Others
    • 4.6.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 5 Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product

  • 5.1 Key segment trends
  • 5.2 Instruments
    • 5.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.3 Reagents
    • 5.3.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 6 Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application

  • 6.1 Key segment trends
  • 6.2 Infectious disease
    • 6.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.2 HIV
      • 6.2.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.3 Influenza
      • 6.2.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.4 Malaria
      • 6.2.4.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.5 Tuberculosis
      • 6.2.5.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.3 Oncology
    • 6.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.4 Blood Screening
    • 6.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.5 Others
    • 6.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 7 Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End-use

  • 7.1 Key segment trends
  • 7.2 Hospitals
    • 7.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 7.3 Diagnostic Laboratories
    • 7.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 7.4 Others
    • 7.4.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 8 Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.2.2 Market size, by technology, 2017 - 2028 (USD Million)
    • 8.2.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.2.4 Market size, by application, 2017 - 2028 (USD Million)
      • 8.2.4.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
    • 8.2.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.2.6 U.S.
      • 8.2.6.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.2.6.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.2.6.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.2.6.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.2.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.2.7 Canada
      • 8.2.7.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.2.7.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.2.7.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.2.7.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.2.7.4 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.3 Europe
    • 8.3.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.3.2 Market size, by technology, 2017 - 2028 (USD Million)
    • 8.3.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.3.4 Market size, by application, 2017 - 2028 (USD Million)
      • 8.3.4.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
    • 8.3.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.6 Germany
      • 8.3.6.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.3.6.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.6.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.3.6.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.3.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.7 UK
      • 8.3.7.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.3.7.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.7.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.3.7.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.3.7.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.8 France
      • 8.3.8.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.3.8.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.8.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.3.8.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.3.8.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.9 Italy
      • 8.3.9.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.3.9.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.9.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.3.9.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.3.9.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.10 Spain
      • 8.3.10.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.3.10.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.10.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.3.10.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.3.10.4 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.4.2 Market size, by technology, 2017 - 2028 (USD Million)
    • 8.4.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.4.4 Market size, by application, 2017 - 2028 (USD Million)
      • 8.4.4.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
    • 8.4.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.6 China
      • 8.4.6.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.4.6.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.6.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.4.6.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.4.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.7 Japan
      • 8.4.7.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.4.7.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.7.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.4.7.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.4.7.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.8 India
      • 8.4.8.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.4.8.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.8.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.4.8.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.4.8.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.9 Australia
      • 8.4.9.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.4.9.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.9.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.4.9.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.4.9.4 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.5.2 Market size, by technology, 2017 - 2028 (USD Million)
    • 8.5.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.5.4 Market size, by application, 2017 - 2028 (USD Million)
      • 8.5.4.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
    • 8.5.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.5.6 Brazil
      • 8.5.6.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.5.6.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.5.6.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.5.6.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.5.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.5.7 Mexico
      • 8.5.7.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.5.7.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.5.7.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.5.7.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.5.7.4 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.6 Middle East & Africa
    • 8.6.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.6.2 Market size, by technology, 2017 - 2028 (USD Million)
    • 8.6.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.6.4 Market size, by application, 2017 - 2028 (USD Million)
      • 8.6.4.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
    • 8.6.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.6.6 Saudi Arabia
      • 8.6.6.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.6.6.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.6.6.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.6.6.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.6.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.6.7 South Africa
      • 8.6.7.1 Market size, by technology, 2017 - 2028 (USD Million)
      • 8.6.7.2 Market size, by product, 2017 - 2028 (USD Million)
      • 8.6.7.3 Market size, by application, 2017 - 2028 (USD Million)
        • 8.6.7.3.1 Market size, by infectious disease, 2017 - 2028 (USD Million)
      • 8.6.7.4 Market size, by end-use, 2017 - 2028 (USD Million)

Chapter 9 Company Profiles

  • 9.1 Competitive dashboard, 2021
  • 9.2 Becton, Dickinson and Company
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 Abbott (Alere)
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 BioMerieux SA
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Eiken Chemical Co. Ltd
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 Hologic Inc. (Gen-Probe)
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 Lucigen
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 Meridian Bioscience, Inc.
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 OptiGene Limited
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
  • 9.10 Qiagen NV
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 Strategic outlook
    • 9.10.5 SWOT analysis
  • 9.11 Quidel Corporation
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis
  • 9.12 Tecan Genomics Inc.
    • 9.12.1 Business overview
    • 9.12.2 Financial data
    • 9.12.3 Product landscape
    • 9.12.4 Strategic outlook
    • 9.12.5 SWOT analysis
  • 9.13 Thermo Fisher Scientific Inc.
    • 9.13.1 Business overview
    • 9.13.2 Financial data
    • 9.13.3 Product landscape
    • 9.13.4 Strategic outlook
    • 9.13.5 SWOT analysis
  • 9.14 Ustar Biotechnologies Ltd.
    • 9.14.1 Business overview
    • 9.14.2 Financial data
    • 9.14.3 Product landscape
    • 9.14.4 Strategic outlook
    • 9.14.5 SWOT analysis
  • 9.15 Grifols, S.A.
    • 9.15.1 Business overview
    • 9.15.2 Financial data
    • 9.15.3 Product landscape
    • 9.15.4 Strategic outlook
    • 9.15.5 SWOT analysis